Editorial Policies

Focus and Scope

The purpose of the journal is familiarization of the scientific community and the community of specialists in various fields of activity with new knowledge and data obtained by researchers in the following areas: Physical Sciences and Engineering, Health Sciences, Social Sciences. 

The multidisciplinarity of the journal, which includes 3 different scientific fields, is justified by the skeleton of the idea underlying the concept of the journal. This concept is presented as follows. 

Industry creates the basis for human well-being and contains the other spheres of human life: health, education, culture, safety. The scientific results obtained for industry are covered in the framework of the concept of the journal by the scientific field “Physical Sciences and Engineering”. 

People working in industry are exposed to risks and occupational diseases. Therefore, their state of health depends on the possibilities of preventing diseases associated with professional activities, their treatment and rehabilitation. The scientific results obtained for medicine are covered in the framework of the journal’s concept by the scientific field “Health Sciences”. 

The creation of goods and their distribution in society, provided by industry, is the basis of human-oriented national economies. However, they are impossible without the creation of such a system of relations between social actors, including in the environment of production relations, which ensures the satisfaction of the material, social, spiritual needs of the individual and social justice in the distribution of vital goods.

The scientific results obtained in the fields of economics, education, sociology, political science, psychology, politics and related scientific disciplines are covered in the framework of the concept of the journal by the scientific field “Social Sciences”. 

Thus, the content of all scientific articles published in the journal allows to consider the possibilities of ensuring decent human well-being from different angles of view.


Section Policies

Innovative technologies in industry

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Occupational diseases

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Innovative technologies in healthcare

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Development of national economies

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Socio-psychological and political aspects of the implementation of innovative technologies

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Social communications in the society development

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Lifelong learning and professional development

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Legal aspects in the system of industrial relations

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Peer Review Process

The editorial board practices double-blind peer review.


Publication Frequency

The journal is published bimonthly.


Open Access Policy

Journal "ScienceRise" is an open access journal. All articles are free for users to access, read, download, and print.



This journal uses LOCKSS system for distributed archiving published content in multiple libraries and information centers. Library - project LOCKSS ensure long-term storage of comprehensive log files and automatically restoring damaged information.


Ethics publications and unfair practices in connection with publications

Ethical Obligations of Editors 

1. All submitted materials are carefully selected and reviewed. An editorial board reserves the right to reject an article or return it as requiring improvement. The author is obliged to improve the article according to the remarks of the reviewers and the editorial board.

2. An editor should considerate all manuscripts offered for publication without prejudice, evaluating each on its merits without regard to race, religion, nationality, status, or institutional affiliation of the author(s). 3. An editor should consider manuscript submitted for publication without delays.

4. The whole responsibility for acceptance or rejection of an article rests with the editor. Responsible and reasonable approach to the duty requires that the editor seek advice from reviewers, Doctor of Science of required specialty, as to the quality and reliability of manuscripts submitted for publication. However, manuscripts may be rejected without external review if considered by the Editors to be inappropriate for the journal.

5. The editor and members of the editor’s staff should not disclose any information about a manuscript under consideration to anyone other than those from whom professional advice is sought. After a positive decision has been made about a manuscript, it should be published in the journal and in the website of the journal.

6. An editor should respect the intellectual independence of authors.

7. Editorial responsibility and authority for any manuscript authored by an editor and submitted to the editor’s journal should be delegated to other qualified person, such as a member of its Editorial Board.

8. If an editor is presented with convincing evidence that the main substance or conclusions of a report published in an editor’s journal are erroneous, the editor should facilitate publication of an appropriate report pointing out the error and, if possible, correcting it. The report may be written by the person who discovered the error or by an original author.

9. An author may request that the editor not use certain reviewers in consideration of a manuscript. However, the editor may decide to use one or more of these reviewers, if the editor feels their opinions are important in the fair consideration of a manuscript. This might be the case, for example, when a manuscript seriously disagrees with the previous work of a potential reviewer.

Ethical Obligations of Authors

1. Main duty of an author is to present an accurate account of the research performed as well as an objective discussion of its significance.

2. An author should be aware that journal space is a limited resource and should use it wisely and economically.

3. A primary research report should contain sufficient detail and reference to public sources of information to permit the author’s peers to repeat the work. When requested, the authors should make a reasonable effort to provide samples of unusual materials unavailable elsewhere, with appropriate material transfer agreements to restrict the field of use of the materials so as to protect the legitimate interests of the authors.

4. An author should cite those publications that have been influential in determining the nature of the reported work and that will guide the reader quickly to the earlier work that is essential for understanding the present investigation. Except in a review, citation of work that will not be referred to in the reported research should be minimized. An author is obligated to perform a literature search to find, and then cite, the original publications that describe closely related work. For critical materials used in the work, proper citation to sources should also be made when these were supplied by a non author.

5. Any unusual hazards appearing during an investigation should be clearly identified in a manuscript reporting the work.

6. Fragmentation of research reports should be avoided. A scientist who has done extensive work on a system or group of related systems should organize publication so that each report gives a well-rounded account of a particular aspect of the general study.

7. In submitting a manuscript for publication, an author should inform the editor of related manuscripts that the author has under editorial consideration or in press. Copies of those manuscripts should be supplied to the editor, and the relationships of such manuscripts to the one submitted should be indicated.

8. It is improper for an author to submit manuscripts describing essentially the same research to more than one journal of primary publication, unless it is a resubmission of a manuscript rejected for or withdrawn from publication. It is generally permissible to submit a manuscript for a full paper expanding on a previously published brief preliminary account (a “communication” or “letter”) of the same work. However, at the time of submission, the editor should be made aware of the earlier communication, and the preliminary communication should be cited in the manuscript.

9. An author should identify the source of all information quoted or offered, except that which is common knowledge. Information obtained privately, as in conversation, correspondence, or discussion with third parties, should not be used or reported in the author’s work without explicit permission from the investigator with whom the information originated. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, should be treated similarly.

10. An experimental or theoretical study may sometimes justify criticism, even severe criticism, of the work of another scientist. When appropriate, such criticism may be offered in published papers. However, in no case is personal criticism considered to be appropriate.

11. The co-authors of a paper should be all those persons who have made significant scientific contributions to the work reported and who share responsibility and accountability for the results. Other contributions should be indicated in a footnote or an “Acknowledgments” section. An administrative relationship to the investigation does not of itself qualify a person for co-authorship (but occasionally it may be appropriate to acknowledge major administrative assistance). Deceased persons who meet the criterion for inclusion as co-authors should be so included, with a footnote reporting date of death. No fictitious name should be listed as an author or coauthor. The author who submits a manuscript for publication accepts the responsibility of having included as co-authors all persons appropriate and none inappropriate. The submitting author should have sent each living co-author a draft copy of the manuscript and have obtained the co-author’s assent to co-authorship of it.

12. The authors should reveal to the editor and to the readers of the journal any potential and/or relevant competing financial or other interest that might be affected by publication of the results contained in the authors’ manuscript. All authors should not have any personal significant financial interest and employment or other relationship with entities that have a financial or other interest which can affect the results described by the manuscript.

Ethical Obligations of Reviewers of Manuscripts

1. As the reviewing of manuscripts is an essential step in the publication process, and therefore in the operation of the scientific method, every scientist has an obligation to do a fair share of reviewing.

2. A chosen reviewer who feels inadequately qualified to judge the research reported in a manuscript should return it promptly to the editor.

3. A reviewer of a manuscript should judge objectively the quality of the manuscript, of its experimental and theoretical work, of its interpretations and its exposition, with due regard to the maintenance of high scientific and literary standards. A reviewer should respect the intellectual independence of the authors.

4. A reviewer should be sensitive to the appearance of a conflict of interest when the manuscript under review is closely related to the reviewer’s work in progress or published. If in doubt, the reviewer should return the manuscript promptly without review, advising the editor of the conflict of interest.

5. A reviewer should not evaluate a manuscript authored or co-authored by a person with whom the reviewer has a personal or professional connection if the relationship would bias judgment of the manuscript.

6. A reviewer should treat a manuscript sent for review as a confidential document. It should neither be shown to nor discussed with others except, in special cases, to persons from whom specific advice may be sought; in that event, the identities of those consulted should be disclosed to the editor.

7. Reviewers should explain and support their judgments adequately so that editors and authors may understand the basis of their comments. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. Unsupported assertions by reviewers (or by authors in rebuttal) are of little value and should be avoided.

8. A reviewer should be alert to failure of authors to cite relevant work by other scientists, bearing in mind that complaints that the reviewer’s own research was insufficiently cited may seem self-serving. A reviewer should call to the editor’s attention any substantial similarity between the manuscript under consideration and any published paper or any manuscript submitted concurrently to another journal.

9. A reviewer should act promptly, submitting a report in a timely manner.

10. Reviewers should not use or disclose unpublished information, arguments, or interpretations contained in a manuscript under consideration, except with the consent of the author. If this information indicates that some of the reviewer’s work is unlikely to be profitable, the reviewer, however, could ethically discontinue the work.


Conflict of interest statement

All manuscripts for types of articles that are submitted to the journal must be accompanied by a conflict of interest disclosure statement or a declaration by the authors that they do not have any conflicts of interest to declare. All articles that are published in the journal must be accompanied by this conflict of interest disclosure statement or a statement that the authors have replied that they have no conflicts of interest to declare. If a journal prints unsigned editorials, they should not have been written by anyone with a conflict of interest.

To facilitate this policy, all authors must privately disclose ‘ALL their potential conflicts of interest’ to the editors of the journal at the time of submission. These include all financial and non-financial interests and relationships, direct employment with a private sector entity (whether full or part-time), and service on private sector and non-profit Boards and advisory panels, whether paid or unpaid. Authors should also disclose any conflict of interest that may have influenced either the conduct or the presentation of the research to the editors, including but not limited to close relationships with those who might be helped or hurt by the publication, academic interests and rivalries, and any personal, religious or political convictions relevant to the topic at hand.

Authors may have strong views about the article being submitted for publication. The authors must consider disclosing these views and the editors may choose to print any affiliations or expressions from these views that may be relevant. These may be personal, political or intellectual, and may include any expression of strongly held views relevant to the subject of submission. Such disclosures may be original or they may be references to opinions previously expressed in books or monographs, opposite editorials or public comments, or to some prior sworn testimony or lobbying of legislators or legislative bodies. Disclosable non-financial conflicts of interest will also include membership or affiliation to non-governmental organizations that have an interest in the submission.

All reviewers that are reviewed manuscripts for the journal must accept by this conflict of interest disclosure statement or a statement that the reviewers have replied that they have no conflicts of interest to declare.

All editors that are worked with manuscripts for the journal must accept by this conflict of interest disclosure statement or a statement that the editors have replied that they have no conflicts of interest to declare.


Bioethics policy

Studies involving animals and humans 

For research manuscripts reporting experiments on living vertebrates and / or higher invertebrates, the correspondent author must confirm that all experiments were performed in accordance with the relevant guidelines and rules. The manuscript should include a statement indicating the institutional and / or licensing committee approving the experiments, including any relevant details. Gender and other characteristics of animals that may affect results should be described. Details of housing and livestock should be included if they can affect experimental results. All animal experiments must comply with ARRIVE guidelines and be conducted in accordance with the Great Britain Animal (Scientific Procedures) Act 1986 and related guidelines or EU Directive 2010/63/EU on the protection of animals used for scientific purposes [http://ec.europa.eu/ environment / chemicals / lab_animals / legislation_en.htm].

For a study in which people are participants, authors must identify a committee approving the study, ensure that the work has been carried out in accordance with the Code of Ethics of the World Medical Association (Helsinki Declaration) and include in your manuscript a statement confirming that informed consent was obtained from all participants (recommendations for obtaining informed consent).

You can also read the Helsinki Declaration in Russian on the website of the Association of Clinical Research Organizations

Clinical trial registration

Prospective clinical trials should be registered prior to the registration of patients on the website or in a similar public store (trials in which the main purpose is to determine pharmacokinetics are excluded.)

Human biological samples

To describe human biological samples, we recommend that you refer to the BRISQ reporting guidelines (reporting on biological samples to improve the quality of the study) and ensure that at least level 1 characteristics are provided (link).

Publication of images of participants in human subject research

When publishing identifiable images of study participants, authors should include a statement in the published article confirming that they have received informed consent to publish the images. All reasonable measures should be taken to protect the anonymity of the patient. Black stripes above the eyes are not an acceptable means of anonymization. In some cases, we may insist on obtaining evidence of the informed consent of the authors. Images without appropriate consent will be removed from the publication.

Studies involving human embryos, gametes, and stem cells

Manuscripts reporting experiments involving the use of human embryos and gametes, human embryonic stem cells and related materials, as well as the clinical use of stem cells, should include confirmation that all experiments have been performed in accordance with relevant guidelines and the rules.

The manuscript should include an ethical statement that identifies the institutional and / or licensing committees that approve the experiments and describe any relevant details. A statement of ethics should also confirm that informed consent has been obtained from all recipients and / or donors of cells or tissues, where necessary, and describe the conditions of donation of research materials, such as human embryos or gametes. The editors may request copies of approved and edited consent documents.

Experiments involving plants or microorganisms

Experiments with plants or microorganisms taken from outside the country of the authors should have been carried out with special permission.

Botanical identity. For each cultivated medicinal plant, its botanical identity must be established and documented - scientific name (variety, species, subspecies / variety, author and family). The common name (if any) must also be indicated in the local and English languages. If necessary, other relevant information should also be indicated, including the name of the cultivar, its ecotype, chemotype and phenotype.

For cultivated plant varieties available for sale, you must specify its name, as well as the supplier. In the case of collection, breeding, distribution and cultivation of landrace in a particular region, the line should be described with its local name, indicating the sources of origin of the seed, plant or sprout material.

Selection of medicinal plants. Where appropriate, the species or botanical species that are selected for cultivation should correspond to those indicated in the national pharmacopoeia or recommended by other authoritative national documents of the country of the final consumer. In the absence of such national documents, the selection of species or botanical varieties should be based on the pharmacopoeia or other authoritative documents of other countries. In the case when medicinal plants are considered for the first time, samples or botanical varieties selected for cultivation should be defined and documented as raw materials used or described in traditional medicine of the country of origin.

Experimental data

Analytical data should be statistically processed using appropriate programs.

When establishing the structure of substances, the authors must provide sufficient experimental information, in particular, the available 1H and 13C NMR spectra, and X-ray crystalline structural determinations are necessary for metal complexes.

The author is responsible for presenting the correct chemical nomenclature and terminology.

An accurate description of each data set should be provided, which is shown and should include the number of biological repeats, the number of experiments performed, and a description and use of appropriate statistical methods. To verify the significance of differences in results, appropriate statistical methods should be used. The term “significant” should not be used unless a statistical analysis has been performed and the probability value used to determine significance (usually p-value) should be indicated. Manuscripts submitted without evidence of reproducibility will be rejected without formal review.

Applications and additional materials 

Authors who wish to publish electronic supplementary materials to their article (Excel files, images, audio and video files) can send these files along with the manuscript.


Plagiarism and duplicate publication

Plagiarism is unacknowledged copying or an attempt to misattribute original authorship, whether of ideas, text or results. Plagiarism can be said to have clearly occurred when large chunks of text have been cut-and-pasted without appropriate and unambiguous attribution. Such manuscripts would not be considered for publication in journal «SciecneRise». "Text recycling" or reuse of parts of text from an author's previous research publication is a form of self-plagiarism.

Duplicate publication occurs when an author reuses substantial parts of his or her own published work without providing the appropriate references. This can range from publishing an identical paper in multiple journals, to only adding a small amount of new data to a previously published paper.

Journal «SciecneRise» editors assess all such cases on their individual merits. When plagiarism becomes evident post-publication, we may correct or retract the original publication depending on the degree of plagiarism, context within the published article and its impact on the overall integrity of the published study.

Material submitted to a «SciecneRise» journal must be original and not published or submitted for publication elsewhere. This rule applies to material submitted elsewhere while the «SciecneRise» journal contribution is under consideration.

All manuscripts submitted for consideration to the journal “SciecneRise” are checked for uniqueness by specialized service StrikePlagiarism.com. A manuscript can be accepted for consideration only if it is unique at least 80%.

Also, in addition, the uniqueness of the manuscript is evaluated at the stage of double-blind peer review (as one of the criteria that is evaluated by reviewers).

If the manuscript was also submitted for consideration in another journal, the authors are required to report this when submitting the manuscript to the journal “SciecneRise”.


Terms of Payment

Publication fee is:

  • 50.00 Euro (publication of an article of 8-12 pages, designed according to the requirements for articles)
  • 90.00 Euro (publication of an article of 8-12 pages, designed according to the requirements for articles + printed copy of the journal)
  • the cost of one additional page, designed according to the requirements of the journal, is 5.00 Euro.

Journal doesn't have article submission charges